nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—SHMT1—blood plasma—schizophrenia	0.0392	0.122	CbGeAlD
Mimosine—CCL2—blood plasma—schizophrenia	0.0363	0.113	CbGeAlD
Mimosine—TYR—blood—schizophrenia	0.0232	0.0723	CbGeAlD
Mimosine—TYR—endocrine gland—schizophrenia	0.0201	0.0627	CbGeAlD
Mimosine—CCL2—forebrain—schizophrenia	0.0199	0.0621	CbGeAlD
Mimosine—CCL2—telencephalon—schizophrenia	0.0183	0.0571	CbGeAlD
Mimosine—SHMT1—gonad—schizophrenia	0.0165	0.0514	CbGeAlD
Mimosine—SHMT1—blood—schizophrenia	0.0144	0.0448	CbGeAlD
Mimosine—L-Tyrosine—TH—schizophrenia	0.0138	0.482	CrCbGaD
Mimosine—CCL2—blood—schizophrenia	0.0133	0.0415	CbGeAlD
Mimosine—CCL2—midbrain—schizophrenia	0.0131	0.041	CbGeAlD
Mimosine—SHMT1—endocrine gland—schizophrenia	0.0125	0.0388	CbGeAlD
Mimosine—SHMT1—nervous system—schizophrenia	0.0117	0.0363	CbGeAlD
Mimosine—CCL2—endocrine gland—schizophrenia	0.0115	0.036	CbGeAlD
Mimosine—SHMT1—central nervous system—schizophrenia	0.0112	0.035	CbGeAlD
Mimosine—SHMT1—cerebellum—schizophrenia	0.011	0.0342	CbGeAlD
Mimosine—CCL2—nervous system—schizophrenia	0.0108	0.0337	CbGeAlD
Mimosine—CCL2—central nervous system—schizophrenia	0.0104	0.0324	CbGeAlD
Mimosine—CCL2—cerebellum—schizophrenia	0.0102	0.0317	CbGeAlD
Mimosine—SHMT1—brain—schizophrenia	0.00891	0.0278	CbGeAlD
Mimosine—CCL2—brain—schizophrenia	0.00826	0.0258	CbGeAlD
Mimosine—L-DOPA—DRD4—schizophrenia	0.00398	0.139	CrCbGaD
Mimosine—SHMT1—Folate Metabolism—MTHFR—schizophrenia	0.00376	0.00577	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—GSK3B—schizophrenia	0.0036	0.00554	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—APOE—schizophrenia	0.00356	0.00547	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—SOD2—schizophrenia	0.00353	0.00543	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—APOA1—schizophrenia	0.00352	0.00541	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—APOA1—schizophrenia	0.00346	0.00531	CbGpPWpGaD
Mimosine—L-DOPA—DRD3—schizophrenia	0.00343	0.12	CrCbGaD
Mimosine—L-DOPA—DRD1—schizophrenia	0.00337	0.118	CrCbGaD
Mimosine—CCL2—AP-1 transcription factor network—IL10—schizophrenia	0.00336	0.00516	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—TPH2—schizophrenia	0.00332	0.0051	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—MTHFR—schizophrenia	0.00311	0.00478	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—schizophrenia	0.00301	0.00463	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—TAAR6—schizophrenia	0.00299	0.0046	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL1B—schizophrenia	0.00293	0.00451	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—APOA1—schizophrenia	0.00286	0.0044	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—NOS1—schizophrenia	0.00284	0.00437	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—SOD2—schizophrenia	0.00281	0.00432	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCK—schizophrenia	0.0028	0.0043	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—NTS—schizophrenia	0.00271	0.00416	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCKAR—schizophrenia	0.00268	0.00412	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ADAMTSL3—schizophrenia	0.00265	0.00407	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—GALNT10—schizophrenia	0.00265	0.00407	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—ESR1—schizophrenia	0.00264	0.00406	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—schizophrenia	0.00262	0.00403	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—FOS—schizophrenia	0.00252	0.00388	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—HTR6—schizophrenia	0.0025	0.00384	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—MTHFR—schizophrenia	0.00247	0.0038	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—NPY—schizophrenia	0.00243	0.00374	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—FZD3—schizophrenia	0.00243	0.00373	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—FOS—schizophrenia	0.00238	0.00365	CbGpPWpGaD
Mimosine—L-DOPA—DRD2—schizophrenia	0.00237	0.083	CrCbGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—TH—schizophrenia	0.00237	0.00363	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—OXT—schizophrenia	0.00235	0.0036	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—BDNF—schizophrenia	0.00232	0.00356	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—TAAR6—schizophrenia	0.00228	0.0035	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—GRM2—schizophrenia	0.00228	0.0035	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—APOA1—schizophrenia	0.00228	0.0035	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IL1B—schizophrenia	0.00227	0.00349	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL1B—schizophrenia	0.00223	0.00343	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—NPS—schizophrenia	0.00222	0.00342	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	0.00221	0.00339	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—IL1B—schizophrenia	0.00214	0.00328	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—TNF—schizophrenia	0.00213	0.00327	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—NTS—schizophrenia	0.00206	0.00317	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—GRM3—schizophrenia	0.00194	0.00298	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—TNF—schizophrenia	0.00192	0.00296	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—HTR6—schizophrenia	0.0019	0.00292	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.00188	0.00288	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PRODH—schizophrenia	0.00185	0.00284	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL1B—schizophrenia	0.00185	0.00284	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.0018	0.00277	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.00175	0.00268	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—EP300—schizophrenia	0.00173	0.00265	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CHRM1—schizophrenia	0.00168	0.00258	CbGpPWpGaD
Mimosine—L-DOPA—CYP2D6—schizophrenia	0.00168	0.0586	CrCbGaD
Mimosine—CCL2—Vitamin B12 Metabolism—TNF—schizophrenia	0.00165	0.00253	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00163	0.00251	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TNF—schizophrenia	0.00162	0.00249	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—EP300—schizophrenia	0.00158	0.00242	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00157	0.00242	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00157	0.00242	CbGpPWpGaD
Mimosine—SHMT1—Disease—NDST3—schizophrenia	0.00157	0.00242	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—FOS—schizophrenia	0.00157	0.00241	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—GRM5—schizophrenia	0.00156	0.0024	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.00151	0.00233	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MPC2—schizophrenia	0.00151	0.00231	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00149	0.00229	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL1B—schizophrenia	0.00147	0.00225	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—DGKI—schizophrenia	0.00146	0.00225	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00146	0.00225	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00146	0.00225	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—MAN2A1—schizophrenia	0.00145	0.00223	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—AKT1—schizophrenia	0.00143	0.0022	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCK—schizophrenia	0.00143	0.0022	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TP53—schizophrenia	0.00143	0.00219	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00142	0.00218	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PLCH2—schizophrenia	0.0014	0.00215	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—DPP4—schizophrenia	0.00139	0.00214	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00138	0.00211	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCKAR—schizophrenia	0.00137	0.00211	CbGpPWpGaD
Mimosine—SHMT1—Disease—IPO5—schizophrenia	0.00136	0.00209	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TNF—schizophrenia	0.00134	0.00206	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PPP1R1B—schizophrenia	0.00134	0.00206	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—ADORA2A—schizophrenia	0.00133	0.00204	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NDST3—schizophrenia	0.00132	0.00202	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00131	0.00202	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.00128	0.00197	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.00128	0.00197	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC27A5—schizophrenia	0.00125	0.00192	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ACSL6—schizophrenia	0.00125	0.00192	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—FZD3—schizophrenia	0.00124	0.00191	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—NPY—schizophrenia	0.00124	0.00191	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—schizophrenia	0.00123	0.0019	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—HTR1B—schizophrenia	0.0012	0.00184	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—OXT—schizophrenia	0.0012	0.00184	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—TP53—schizophrenia	0.0012	0.00184	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—DAO—schizophrenia	0.00119	0.00183	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TP53—schizophrenia	0.00118	0.00182	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRM2—schizophrenia	0.00117	0.0018	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—TAAR6—schizophrenia	0.00117	0.0018	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PPP3CC—schizophrenia	0.00117	0.0018	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL1B—schizophrenia	0.00116	0.00178	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—AKT1—schizophrenia	0.00115	0.00177	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—HTR1A—schizophrenia	0.00115	0.00177	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PNP—schizophrenia	0.00114	0.00175	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—NPS—schizophrenia	0.00114	0.00175	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TP53—schizophrenia	0.00113	0.00173	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—DRD1—schizophrenia	0.00111	0.00171	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—HTR2C—schizophrenia	0.00111	0.00171	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NGEF—schizophrenia	0.00108	0.00166	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—DRD3—schizophrenia	0.00108	0.00166	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—TNF—schizophrenia	0.00106	0.00164	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NDUFV2—schizophrenia	0.00106	0.00163	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NTS—schizophrenia	0.00106	0.00163	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—DRD4—schizophrenia	0.00105	0.00161	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—TNF—schizophrenia	0.00103	0.00158	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—AKT1—schizophrenia	0.00101	0.00155	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CNR1—schizophrenia	0.001	0.00154	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIP4K2A—schizophrenia	0.000998	0.00153	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—RGS4—schizophrenia	0.000995	0.00153	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRM3—schizophrenia	0.000995	0.00153	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HTR6—schizophrenia	0.000977	0.0015	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—DRD2—schizophrenia	0.000975	0.0015	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—HTR7—schizophrenia	0.000975	0.0015	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP26B1—schizophrenia	0.000902	0.00139	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.000897	0.00138	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DGKI—schizophrenia	0.000865	0.00133	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CHRM1—schizophrenia	0.000863	0.00133	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TNF—schizophrenia	0.000842	0.00129	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL3RA—schizophrenia	0.000841	0.00129	CbGpPWpGaD
Mimosine—SHMT1—Disease—NRG3—schizophrenia	0.000835	0.00128	CbGpPWpGaD
Mimosine—SHMT1—Disease—TLE1—schizophrenia	0.000835	0.00128	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GCLM—schizophrenia	0.000804	0.00124	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TPH1—schizophrenia	0.000804	0.00124	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRM5—schizophrenia	0.000802	0.00123	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PPP1R1B—schizophrenia	0.000791	0.00122	CbGpPWpGaD
Mimosine—SHMT1—Disease—TLE3—schizophrenia	0.000791	0.00122	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—AKT1—schizophrenia	0.000765	0.00118	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PRKD1—schizophrenia	0.000756	0.00116	CbGpPWpGaD
Mimosine—SHMT1—Disease—GAPDH—schizophrenia	0.000754	0.00116	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TP53—schizophrenia	0.000742	0.00114	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FZD3—schizophrenia	0.000735	0.00113	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCK—schizophrenia	0.000734	0.00113	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ACE—schizophrenia	0.000719	0.00111	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PDE4B—schizophrenia	0.000715	0.0011	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCKAR—schizophrenia	0.000703	0.00108	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TAAR6—schizophrenia	0.000691	0.00106	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PPP3CC—schizophrenia	0.000691	0.00106	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRM2—schizophrenia	0.000691	0.00106	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FES—schizophrenia	0.000691	0.00106	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—HTR2A—schizophrenia	0.000683	0.00105	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ADORA2A—schizophrenia	0.000682	0.00105	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGA—schizophrenia	0.000666	0.00102	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NGEF—schizophrenia	0.00064	0.000983	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NPY—schizophrenia	0.000637	0.000979	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GAPDH—schizophrenia	0.000631	0.00097	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CLOCK—schizophrenia	0.000625	0.000961	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NTS—schizophrenia	0.000625	0.000961	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HTR1B—schizophrenia	0.000615	0.000945	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—OXT—schizophrenia	0.000615	0.000945	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TPH2—schizophrenia	0.00061	0.000937	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CACNB2—schizophrenia	0.00061	0.000937	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—DPYD—schizophrenia	0.0006	0.000921	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HTR1A—schizophrenia	0.000592	0.000909	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRM3—schizophrenia	0.000588	0.000903	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RGS4—schizophrenia	0.000588	0.000903	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RTN4—schizophrenia	0.000588	0.000903	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NPS—schizophrenia	0.000583	0.000896	CbGpPWpGaD
Mimosine—SHMT1—Disease—SNAP25—schizophrenia	0.000582	0.000894	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HTR6—schizophrenia	0.000577	0.000887	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—DRD1—schizophrenia	0.000572	0.000878	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HTR2C—schizophrenia	0.000572	0.000878	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CACNA1C—schizophrenia	0.000557	0.000857	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAG—schizophrenia	0.000557	0.000856	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—DRD3—schizophrenia	0.000554	0.000851	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3C2A—schizophrenia	0.000543	0.000835	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—DRD4—schizophrenia	0.000537	0.000826	CbGpPWpGaD
Mimosine—SHMT1—Disease—HSPA1A—schizophrenia	0.000522	0.000803	CbGpPWpGaD
Mimosine—SHMT1—Disease—NOS1—schizophrenia	0.000519	0.000797	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CNR1—schizophrenia	0.000513	0.000788	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CHRM1—schizophrenia	0.00051	0.000783	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—DRD2—schizophrenia	0.000501	0.000769	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HTR7—schizophrenia	0.000501	0.000769	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL3RA—schizophrenia	0.000497	0.000763	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP2D6—schizophrenia	0.000487	0.000749	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SNAP25—schizophrenia	0.000487	0.000749	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NRG3—schizophrenia	0.000485	0.000745	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TLE1—schizophrenia	0.000485	0.000745	CbGpPWpGaD
Mimosine—SHMT1—Disease—PRL—schizophrenia	0.000481	0.00074	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GFAP—schizophrenia	0.000479	0.000736	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRM5—schizophrenia	0.000474	0.000728	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TLE3—schizophrenia	0.000459	0.000705	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP1A2—schizophrenia	0.000441	0.000677	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TH—schizophrenia	0.000434	0.000667	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCK—schizophrenia	0.000433	0.000666	CbGpPWpGaD
Mimosine—SHMT1—Disease—ERBB4—schizophrenia	0.000429	0.000659	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDE4B—schizophrenia	0.000422	0.000649	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCKAR—schizophrenia	0.000415	0.000638	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADORA2A—schizophrenia	0.000403	0.000619	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PLA2G4A—schizophrenia	0.000396	0.000609	CbGpPWpGaD
Mimosine—SHMT1—Disease—NRG1—schizophrenia	0.000396	0.000608	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGA—schizophrenia	0.000386	0.000594	CbGpPWpGaD
Mimosine—SHMT1—Disease—YWHAZ—schizophrenia	0.000379	0.000583	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NPY—schizophrenia	0.000376	0.000578	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NOTCH4—schizophrenia	0.000376	0.000578	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ATP2A2—schizophrenia	0.000376	0.000578	CbGpPWpGaD
Mimosine—SHMT1—Disease—ERBB3—schizophrenia	0.000371	0.00057	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—COMT—schizophrenia	0.000369	0.000567	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTP1—schizophrenia	0.000368	0.000565	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MAOA—schizophrenia	0.000367	0.000563	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HTR1B—schizophrenia	0.000363	0.000558	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—OXT—schizophrenia	0.000363	0.000558	CbGpPWpGaD
Mimosine—SHMT1—Disease—MTHFR—schizophrenia	0.000356	0.000548	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HTR2A—schizophrenia	0.000351	0.000539	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HTR1A—schizophrenia	0.00035	0.000537	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCB1—schizophrenia	0.000348	0.000535	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NPS—schizophrenia	0.000344	0.000529	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTM1—schizophrenia	0.000338	0.000519	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PLA2G4A—schizophrenia	0.000338	0.000519	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DRD1—schizophrenia	0.000338	0.000519	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HTR2C—schizophrenia	0.000338	0.000519	CbGpPWpGaD
Mimosine—SHMT1—Disease—APOE—schizophrenia	0.000332	0.00051	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NTRK2—schizophrenia	0.000328	0.000505	CbGpPWpGaD
Mimosine—SHMT1—Disease—APOA1—schizophrenia	0.000328	0.000504	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DRD3—schizophrenia	0.000327	0.000502	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DRD4—schizophrenia	0.000317	0.000488	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CNR1—schizophrenia	0.000303	0.000466	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MTHFR—schizophrenia	0.000299	0.000459	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DRD2—schizophrenia	0.000296	0.000454	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HTR7—schizophrenia	0.000296	0.000454	CbGpPWpGaD
Mimosine—SHMT1—Disease—GSK3B—schizophrenia	0.000287	0.000442	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRL—schizophrenia	0.000279	0.000429	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOE—schizophrenia	0.000278	0.000427	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOA1—schizophrenia	0.000275	0.000422	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—S100B—schizophrenia	0.00026	0.0004	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ERBB4—schizophrenia	0.000249	0.000382	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PLA2G4A—schizophrenia	0.000234	0.00036	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NRG1—schizophrenia	0.00023	0.000353	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MEF2C—schizophrenia	0.000228	0.00035	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—YWHAZ—schizophrenia	0.00022	0.000338	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ERBB3—schizophrenia	0.000215	0.000331	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HTR2A—schizophrenia	0.000207	0.000318	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APOE—schizophrenia	0.000193	0.000296	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APOA1—schizophrenia	0.00019	0.000292	CbGpPWpGaD
Mimosine—SHMT1—Disease—EP300—schizophrenia	0.000189	0.000291	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ESR1—schizophrenia	0.000184	0.000282	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GSK3B—schizophrenia	0.000167	0.000256	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—EP300—schizophrenia	0.000158	0.000243	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT1—schizophrenia	0.000114	0.000176	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT1—schizophrenia	0.000112	0.000172	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EP300—schizophrenia	0.00011	0.000169	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKT1—schizophrenia	9.57e-05	0.000147	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TP53—schizophrenia	7.85e-05	0.000121	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT1—schizophrenia	6.63e-05	0.000102	CbGpPWpGaD
